Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Laurantis Pharma Oy

Latest From Laurantis Pharma Oy

Recent Financings Of Private Companies, October 2012

START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Dermatology
  • Ophthalmic
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Finland
  • Parent & Subsidiaries
  • Laurantis Pharma Oy
  • Senior Management
  • Riku Rautsola, PhD, CEO
    Lasse Leino, PhD, COO
    Jarmo Laihia, PhD, CSO
  • Contact Info
  • Laurantis Pharma Oy
    Phone: 2 4788 378
    Itäinen Pitkäkatu 4 B
    Turku, FI-20520